Bacillus megateriumP450 BM3 is a fatty acid hydroxylase with selectivity for long chain substrates (C12–C20). Binding or activity with substrates of chain length 12has not been reported. Rational mutagenesis was used to re‐design the enzyme to encourage binding of short chain fatty acids (C4–C10). We show that wild‐type P450 BM3 has activity and weak affinity for substrates as short as butyrate (C4). However, turnover/binding of short chain substrates is dramatically increased by introducing a novel substrate carboxylate binding site close to the heme. Mutant L181K shows catalytic efficiency (kcat/KM) increased >13‐fold with butyrate, while the L75T/L181K double mutant haskcat/KMincreased >15‐fold with hexanoate and binding (Kd) improved >28‐fold for butyrate. Removing the arginine 47/lysine 51 carboxylate binding motif at the mouth of the active site disfavours binding of all fatty acids, indicating its importance in the initial recognition of substrates.
No takes yet. Share an insight, caveat, or question.
Ost et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: